ES Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ES Pharma
Largest movements
- Receivables within one year +€9,633
up €9,633 (+340.0%), from €2,833 to €12,466
of which Trade receivables: +€12,342
- Tangible fixed assets +€4,520
up €4,520 (+1594.4%), from €284 to €4,804
- Cash +€3,807
up €3,807 (+4.0%), from €96,292 to €100,099
mainly Net result for the year (+€16,341) and Other debts (+€16,341)
- Other debts +€16,341
new in 2025: €16,341
- Tax, wage and social debts +€2,205
up €2,205 (+28.4%), from €7,771 to €9,976
of which Taxes: +€2,188
- Gross operating margin +€8,322
up €8,322 (+56.6%), from €14,711 to €23,033
- Taxes -€1,490
down €1,490 (-24.8%), from €5,997 to €4,508
- Depreciation -€352
down €352 (-53.4%), from €659 to €308
- Other operating charges -€280
down €280 (-15.6%), from €1,793 to €1,513
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €99,710 | €117,670 | +€17,960 | +18.0% |
| Fixed assets | 21/28 | €584 | €5,105 | +€4,520 | +773.4% |
| Tangible fixed assets | 22/27 | €284 | €4,804 | +€4,520 | +1594.4% |
| Furniture and vehicles | 24 | €284 | €4,804 | +€4,520 | +1594.4% |
| Financial fixed assets | 28 | €301 | €301 | = | 0.0% |
| Current assets | 29/58 | €99,125 | €112,565 | +€13,440 | +13.6% |
| Amounts receivable within one year | 40/41 | €2,833 | €12,466 | +€9,633 | +340.0% |
| Trade receivables | 40 | - | €12,342 | +€12,342 | |
| Other amounts receivable | 41 | €2,833 | €124 | -€2,709 | -95.6% |
| Cash at bank and in hand | 54/58 | €96,292 | €100,099 | +€3,807 | +4.0% |
| Total equity and liabilities | 10/49 | €99,710 | €117,670 | +€17,960 | +18.0% |
| Equity | 10/15 | €90,644 | €90,644 | = | 0.0% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Capital | 10 | €20,000 | - | -€20,000 | |
| Issued capital | 100 | €20,000 | - | -€20,000 | |
| Outside capital | 11 | - | €20,000 | +€20,000 | |
| Other | 1109/19 | - | €20,000 | +€20,000 | |
| Reserves | 13 | €26,000 | €26,000 | = | 0.0% |
| Distributable reserves | 133 | €26,000 | €26,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €44,644 | €44,644 | = | 0.0% |
| Amounts payable | 17/49 | €9,065 | €27,025 | +€17,960 | +198.1% |
| Amounts payable within one year | 42/48 | €9,065 | €27,025 | +€17,960 | +198.1% |
| Trade debts | 44 | €1,294 | €709 | -€585 | -45.2% |
| Suppliers | 440/4 | €1,294 | €709 | -€585 | -45.2% |
| Taxes, remuneration and social security | 45 | €7,771 | €9,976 | +€2,205 | +28.4% |
| Taxes | 450/3 | €5,844 | €8,032 | +€2,188 | +37.4% |
| Remuneration and social security | 454/9 | €1,927 | €1,943 | +€16 | +0.8% |
| Other amounts payable | 47/48 | - | €16,341 | +€16,341 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €659 | €308 | -€352 | -53.4% |
| Other operating charges | 640/8 | €1,793 | €1,513 | -€280 | -15.6% |
| Non-recurring operating charges | 66A | - | €217 | +€217 | |
| Gross operating margin | 9900 | €14,711 | €23,033 | +€8,322 | +56.6% |
| Operating profit (loss) | 9901 | €12,258 | €20,994 | +€8,736 | +71.3% |
| Financial charges | 65/66B | €166 | €146 | -€20 | -12.0% |
| Recurring financial charges | 65 | €166 | €146 | -€20 | -12.0% |
| Profit (loss) for the period before taxes | 9903 | €12,092 | €20,848 | +€8,756 | +72.4% |
| Income taxes | 67/77 | €5,997 | €4,508 | -€1,490 | -24.8% |
| Profit (loss) for the period | 9904 | €6,095 | €16,341 | +€10,246 | +168.1% |
| Profit (loss) for the period to be appropriated | 9905 | €6,095 | €16,341 | +€10,246 | +168.1% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.